Sinclair Michael's Form 4 filing
Opiant Pharmaceuticals, Inc. (OPNT) · filed Jun 6, 2022
- Accession no.
- 0001385508-22-000068
- Filed
- Jun 6, 2022
- Trade date
- Jun 2-3, 2022
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 2 non-derivative transactions. Open-market sales total $274.6K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Sinclair MichaelCIK 0001551246 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2022 | Common Stock | SSaleDisposed | −9,736 | $13.88 | −$135,135.68 | 59,484 | Direct | |
| Jun 3, 2022 | Common Stock | SSaleDisposed | −10,264 | $13.59 | −$139,487.76 | 49,220 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.